BCM
MRNA icon

Brookstone Capital Management’s Moderna MRNA Stock Holding History

Brookstone Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,545
Closed -$330K – 819
2021
Q4 		$330K Sell
1,545
-5,145
-77% -$1.5M 0.01% 607
2021
Q3 		$2.15M Buy
6,690
+5,786
+640% +$2.13M 0.04% 266
2021
Q2 		$213K Buy
+904
New +$162K ﹤0.01% 669
2020
Q3 		– Sell
-5,756
Closed -$370K – 458
2020
Q2 		$370K Buy
+5,756
New +$315K 0.02% 268

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Brookstone Capital Management's MRNA Position: Q1 2022 in Review

Brookstone Capital Management sold out of Moderna (MRNA) in Q1 2022, closing a stake of 1,545 shares — an estimated $330K sold.

Brookstone Capital Management first reported a position in MRNA in Q2 2020 and held it in 4 quarters. The position peaked at $2.15M in Q3 2021. 1,006 funds tracked by Wall St. Rank hold MRNA as of Q1 2022.

  • Brookstone Capital Management reported no remaining Moderna position as of Q1 2022 after selling out during the quarter.
  • Brookstone Capital Management sold 1,545 Moderna shares in Q1 2022, an estimated $330K.
  • Brookstone Capital Management first reported a position in Moderna in Q2 2020 and held it in 4 quarters.
  • Brookstone Capital Management's Moderna position peaked at $2.15M in Q3 2021.
  • 1,006 funds tracked by Wall St. Rank held Moderna as of Q1 2022.

Based on Brookstone Capital Management's 13F filing for Q1 2022, filed 12 Apr 2022.